China SXT Pharmaceuticals, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SXTC research report →
Companywww.sxtchina.com
China SXT Pharmaceuticals, Inc. , a pharmaceutical company, engages in the research, development, manufacture, marketing, and sale of traditional Chinese medicine pieces (TCMP) in China. The company offers advanced, fine, and regular TCMP products, and raw medicinal material, such as SanQiFen, HongQi, SuMu, JiangXiang, CuYanHuSuo, XiaTianWu, LuXueJing, XueJie, ChaoSuanZaoRen, HongQuMi, ChuanBeiMu, HuangShuKuiHua, WuWeiZi, DingXiang, RenShen, QingGuo, JueMingZi, ShaRen, and ChenXiang.
- CEO
- Feng Zhou
- IPO
- 2019
- Employees
- 75
- HQ
- Taizhou, CN
Price Chart
Valuation
- Market Cap
- $1.24M
- P/E
- -1.56
- P/S
- 1.36
- P/B
- 0.19
- EV/EBITDA
- 9.23
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 25.53%
- Op Margin
- -224.07%
- Net Margin
- -274.42%
- ROE
- -14.68%
- ROIC
- -9.53%
Growth & Income
- Revenue
- $1.74M · -9.73%
- Net Income
- $-3,303,652 · -6.62%
- EPS
- $-8.18 · -129.13%
- Op Income
- $-2,680,479
- FCF YoY
- -21.30%
Performance & Tape
- 52W High
- $1047.00
- 52W Low
- $1.25
- 50D MA
- $1.84
- 200D MA
- $127.43
- Beta
- 1.96
- Avg Volume
- 51.47K
Get TickerSpark's AI analysis on SXTC
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 31, 22 | Pan Xiaodong Sean | other | 0 |
| Jul 4, 17 | Zhou Feng Felix | other | 0 |
| Jan 20, 25 | Chee Yong Lip | other | 0 |
| May 22, 21 | Ji Xiaodong | other | 0 |
| May 10, 22 | Liu Tong Tony | other | 0 |
| Jan 20, 25 | Simon Lim Sze Beng | other | 0 |
| Dec 31, 18 | Zheng Jun | other | 0 |
Our SXTC Coverage
We haven't published any research on SXTC yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SXTC Report →